Effects of unmeasured heterogeneity in the linear transformation model for censored data

DOI10.1007/S10985-006-9008-YMaRDI QIDQ849905zbMATH OpenOpenAlexWikidataFDO

Authors Bin Zhang, Yi Li, Rebecca A. Betensky

Publication date 15 November 2006

Published in Lifetime Data Analysis (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1007/s10985-006-9008-y

zbMATH Keywords

frailtyomitted covariate

Mathematics Subject Classification ID

Censored data models (62N01) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Effect of Frailty on Marginal Regression Estimates in Survival Analysis
• The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power
• Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
• A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials
• scientific article; zbMATH DE number 124958

Cites work

• scientific article; zbMATH DE number 4090580 (Why is no real title available?)
• Analysis of transformation models with censored data
• Consistency of the NPML Estimator in the Right-Censored Transformation Model
• Effect of misspecification of regression models in the analysis of survival data
• Efficient semiparametric estimators via modified profile likelihood
• Properties of Proportional-Hazards Score Tests under Misspecified Regression Models
• Robust inference for univariate proportional hazards frailty regression models
• The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power

Cited in

(5)

• Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
• The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power
• Erratum to: ``Effects of unmeasured heterogeneity in the linear transformation model for censored data
• The effect of treatment delay on time-to-recovery in the presence of unobserved heterogeneity
• Designed extension of survival studies: application to clinical trials with unrecognized hetero\-ge\-neity

This page was built for publication: Effects of unmeasured heterogeneity in the linear transformation model for censored data

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q849905)